SANTA ANA, CA--(Marketwired - Apr 12, 2016) - BioLargo, Inc. (OTCQB: BLGO), inventor of patented iodine based disinfection technologies, announced that its Canadian subsidiary BioLargo Water, Inc. has started a prototype development project for its AOS Filter technology.

Following extensive validation testing and refinement of the basic operating system, this project is the next step leading to a product ready for commercial markets. The project will be executed in collaboration with technical personnel at the Northern Alberta Institute of Technology (NAIT)'s Center for Sensors and Systems Integration and with NAIT's Applied Bio/Nanotechnology Industrial Research Chair.

BioLargo's AOS Filter combines iodine, water filter materials and electrolysis within a water filter device to disinfect and eliminate contaminants in water. The technology is proven to eliminate infectious biological pathogens such as Salmonella, Listeria and E.coli.

With financial support provided by the Alberta Innovates nanoPDP program, this project will focus on the development of a first generation prototype system that incorporates a sensor platform to monitor various water parameters through online real-time data acquisition. This platform will be integrated with BioLargo's pre-commercial AOS reactor, and will enable further scale up and testing in industrial settings. Once this prototype development phase is complete, the company will focus on producing multiple commercial ready pilot units for testing with various interested industrial clients and on securing regulatory approvals where required.

Dr. Richard Smith, President of BioLargo Water, commented, "NAIT's expertise in sensor technology and process scale up is a critical component to a commercial ready AOS filter. We hope to have this prototype unit to showcase at our second annual technical symposium scheduled summer 2016."

Dennis P. Calvert, President and CEO of BioLargo, Inc. commented, "Excitement for our AOS Filter's commercial future is expanding as the water industry searches for high performance and cost saving technical solutions to deliver clean water. Our AOS Technology is transformative and expanding in scope and importance. These next steps in our journey to commercialization will enable us and any of our future partners to begin manufacturing and large scale up efforts as well as to customize the AOS Filter to suit the special needs of larger customers."

NAIT's Centre for Sensors and Systems Integration (CSSI) is a research center funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). Created to partner with small and medium enterprises seeking coordinated innovation development services, the center is staffed with highly qualified specialists and technologists experienced in providing prototype development solutions, helping industry partners develop prototype devices that address sensor-based challenges. Working with both established sensor devices and new or innovative devices, the CSSI team uses engineering technology to produce and evaluate prototypes for field trial.

The Applied Bio/Nanotechnology Industrial Research (ABNIR) Chair at NAIT supports regional industries with the implementation of emerging nanotechnologies through prototype development and scale up in the areas of materials science and process engineering. ABNIR operate as an industry-driven, highly multidisciplinary applied research facility fully integrated with the Campus Alberta system.

About BioLargo, Inc.

BioLargo, Inc. (BLGO) makes life better by delivering sustainable technology-based products that help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter -- a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry and is named the Technology Innovation Leader in the water treatment market by Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project now being commercialized under a license to Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.